• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝内胆管癌中的E-钙黏蛋白基因突变

E-cadherin gene mutations in human intrahepatic cholangiocarcinoma.

作者信息

Endo K, Ashida K, Miyake N, Terada T

机构信息

Second Department of Pathology, Tottori University, Faculty of Medicine, 86 Nishi-cho, Yonago 683-8503, Tottori, Japan.

出版信息

J Pathol. 2001 Mar;193(3):310-7. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH816>3.0.CO;2-K.

DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH816>3.0.CO;2-K
PMID:11241409
Abstract

Deletions or mutations of the E-cadherin gene may result in reduced cell adhesiveness. In particular, conservative point mutations within the N-terminal calcium-binding pocket (including exons 7, 8, and 9) are frequently detected in several cancers and are enough to abolish cell-cell adhesion. There have been no studies on E-cadherin gene mutations in human intrahepatic cholangiocarcinoma (ICC). Human ICCs were therefore investigated for E-cadherin gene mutations within exons 7, 8, and 9. In addition, the relationships were analysed between their mutations and the immunohistochemical expression of E-cadherin, histological grade, and clinicopathological parameters. The E-cadherin gene was analysed in 34 tumours by nested polymerase chain reaction/single-strand conformation polymorphism (PCR/SSCP) followed by DNA sequencing. In four of the 34 cases (11.8%), tumour-restricted mobility shifts were observed; two cases harboured a single shift, one case presented two different mobility shifts, and one case presented three different mobility shifts within exons 7 and 8, encoding extracellular domains of E-cadherin. Polymorphism as previously reported was not identified and all seven new DNA alterations were not present in genomic DNA of non-tumour origin. The E-cadherin gene mutations correlated significantly with down-regulated E-cadherin protein expression and high ICC histological grade. These data suggest that E-cadherin gene mutations in ICC are associated with reduced cell adhesiveness and high histological grade.

摘要

E-钙黏蛋白基因的缺失或突变可能导致细胞黏附性降低。特别是,在几种癌症中经常检测到N端钙结合口袋内的保守点突变(包括外显子7、8和9),这些突变足以消除细胞间黏附。目前尚无关于人类肝内胆管癌(ICC)中E-钙黏蛋白基因突变的研究。因此,我们对人类ICC进行了研究,以检测外显子7、8和9内的E-钙黏蛋白基因突变。此外,还分析了这些突变与E-钙黏蛋白的免疫组化表达、组织学分级及临床病理参数之间的关系。通过巢式聚合酶链反应/单链构象多态性(PCR/SSCP)及DNA测序对34个肿瘤中的E-钙黏蛋白基因进行了分析。在34例中的4例(11.8%)观察到肿瘤特异性迁移率改变;2例有单一迁移率改变,1例在编码E-钙黏蛋白细胞外结构域的外显子7和8内有两种不同的迁移率改变,1例有三种不同的迁移率改变。未发现先前报道的多态性,且所有7种新的DNA改变均不存在于非肿瘤来源的基因组DNA中。E-钙黏蛋白基因突变与E-钙黏蛋白蛋白表达下调及ICC高组织学分级显著相关。这些数据表明,ICC中的E-钙黏蛋白基因突变与细胞黏附性降低和高组织学分级有关。

相似文献

1
E-cadherin gene mutations in human intrahepatic cholangiocarcinoma.人肝内胆管癌中的E-钙黏蛋白基因突变
J Pathol. 2001 Mar;193(3):310-7. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH816>3.0.CO;2-K.
2
Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.肝内胆管癌中β-连环蛋白表达改变但无基因突变
Mod Pathol. 2001 Sep;14(9):900-5. doi: 10.1038/modpathol.3880409.
3
Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.14-3-3ζ在肝内胆管癌中的表达上调及其临床意义
Tumour Biol. 2015 Mar;36(3):1781-9. doi: 10.1007/s13277-014-2780-5. Epub 2014 Nov 13.
4
KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis-free survival and reduced E-cadherin expression.肝内胆管癌中的 KRAS 突变:与无转移生存期相关,并降低 E-钙黏蛋白表达。
Liver Int. 2022 Oct;42(10):2329-2340. doi: 10.1111/liv.15366. Epub 2022 Jul 25.
5
An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.免疫组化染色 C 反应蛋白、N-钙黏蛋白和 S100 钙结合蛋白 P 有助于肝内胆管癌分型。
Hum Pathol. 2021 Mar;109:45-52. doi: 10.1016/j.humpath.2020.12.005. Epub 2020 Dec 13.
6
Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression.病毒性肝炎与具有胆管分化和 N-钙黏蛋白表达的肝内胆管癌相关。
Mod Pathol. 2011 Jun;24(6):810-9. doi: 10.1038/modpathol.2011.41. Epub 2011 Mar 18.
7
Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.肝内胆管癌中p53和K-ras的突变以及APC的杂合性缺失
Lab Invest. 1999 Apr;79(4):477-83.
8
FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma.肝内胆管癌中的脂肪、E-钙黏蛋白、β-连环蛋白、HER 2/neu、Ki67免疫表达及组织学分级
J Clin Pathol. 2005 Dec;58(12):1249-54. doi: 10.1136/jcp.2005.026575.
9
Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.P-钙黏蛋白过表达在肝内胆管癌和胰腺癌中的意义及其调控的可能机制
Cancer Sci. 2015 Sep;106(9):1153-62. doi: 10.1111/cas.12732. Epub 2015 Aug 18.
10
The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma.E-钙黏蛋白抑制因子slug 与肝外胆管上段癌的演进。
J Exp Clin Cancer Res. 2010 Jul 1;29(1):88. doi: 10.1186/1756-9966-29-88.

引用本文的文献

1
Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the 'NSCLC' of GI Oncology?胆管癌靶向治疗格局的演变:胆管癌是胃肠道肿瘤学中的“非小细胞肺癌”吗?
Cancers (Basel). 2023 Mar 3;15(5):1578. doi: 10.3390/cancers15051578.
2
Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy.胆管癌中的基因组改变:临床意义及其与治疗的相关性。
Explor Target Antitumor Ther. 2022;3(2):200-223. doi: 10.37349/etat.2022.00079. Epub 2022 Apr 26.
3
Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma.
肝细胞癌和胆管癌的药物遗传学
Cancer Drug Resist. 2019 Sep 19;2(3):680-709. doi: 10.20517/cdr.2019.006. eCollection 2019.
4
Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.肝内胆管癌的染色体拷贝数改变模式
BMC Cancer. 2015 Mar 14;15:126. doi: 10.1186/s12885-015-1111-6.
5
Molecular diagnosis of intrahepatic cholangiocarcinoma.肝内胆管癌的分子诊断
J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):114-23. doi: 10.1002/jhbp.156. Epub 2014 Sep 29.
6
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.综合基因组特征揭示了散发性肝内胆管癌中FGFR和EGFR通路中新型的、具有治疗相关性的药物靶点。
PLoS Genet. 2014 Feb 13;10(2):e1004135. doi: 10.1371/journal.pgen.1004135. eCollection 2014 Feb.
7
The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.胆管癌的挑战:剖析阴险癌症的分子机制。
Dis Model Mech. 2013 Mar;6(2):281-92. doi: 10.1242/dmm.010561.
8
Genetic profiling of intrahepatic cholangiocarcinoma.肝内胆管癌的基因谱分析。
Curr Opin Gastroenterol. 2012 May;28(3):266-72. doi: 10.1097/MOG.0b013e3283523c7e.
9
Involvement of members of the cadherin superfamily in cancer.钙黏蛋白超家族成员在癌症中的作用。
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a003129. doi: 10.1101/cshperspect.a003129. Epub 2009 Sep 23.
10
Recent advances in the regulation of cholangiocarcinoma growth.胆管癌生长调控的最新进展。
Am J Physiol Gastrointest Liver Physiol. 2010 Jul;299(1):G1-9. doi: 10.1152/ajpgi.00114.2010. Epub 2010 Apr 29.